Treatment Approaches in Advanced RCC

The University of Kansas Cancer Center
J

The Role of Radiation Therapy in Renal Cell Carcinoma

By The University of Kansas Cancer Center FEATURING Jay Shiao
By The University of Kansas Cancer Center FEATURING Jay Shiao
244 views
May 23, 2023
0 Comments
Login to view comments. Click here to Login
11:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Prespecified OS Analysis of CLEAR -…

Feat. T. Hutson
11:46
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "EV-103 Dose Escalation/Cohort A - Long-Te…

Feat. S. Gupta
07:42
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Analysis of Pt-Level Data From SWOG-1216 …

Feat. N. Sayegh
23:57
ecancer

ASCO® 2023 Summary: "Key Trials in mRCC"

Feat. J. Puente, C. Suárez, S. Oudard, V. Grünwald
19:50
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Adding Clarity to Non-Clear Cell Carcinom…

Feat. M. Schmidinger
08:22
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy and Safety Analysis of Sacituzum…

Feat. S. Tagawa
05:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "FGFR3 Alterations in Phase III PROOF 302 …

Feat. P. Grivas
17:31
The University of Kansas Cancer Center

Updates in Renal Cell Carcinoma

Feat. S. Abbasi
13:37
SIR 2023 Conference Coverage

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

Feat. N. Kothary
14:36
OncoAlert

RCC Updates: Perioperative Treatment, Metastatic ccRCC, and Non-Clea…

Feat. T. Choueiri
10:29
UC Irvine Health

Molecular Characteristics of Advanced ccRCC Harboring TERT Mutations

Feat. N. Mar
15:35
Dana-Farber Cancer Institute

Updates on the Management of Non-Clear Cell RCC

Feat. B. McGregor
07:39
Total Health

2023 Case-Based Clinical Updates in RCC: 69 y/o Male With Clear Cell…

Feat. D. Vaena
15:50
Pavlos Msaouel

First-Line Treatment Options in Advanced RCC: How to Choose

07:10
Viktor Grünwald

Updated Results From the CLEAR Trial: Outcomes of the Combination of…

15:17
ASCO GU 2023 Conference Coverage

ASCO GU 2023 Systemic Therapy for Recurrent Metastatic RCC: Beyond S…

Feat. T. Zhang
56:06
Yale Cancer Center

Determinants of Effective Anti-Tumor Immunity in Kidney Cancer

Feat. D. Braun
14:14
PrecisCa

GU Tumor Board: 61 y/o Male With mRCC With Disease Progression After…

Feat. M. Rettig, S. Slovin, T. Fraum, J. Abel, P. Patel
08:16
PrecisCa

Preferred Modality for Follow-Up Imaging After Definitive Treatment …

Feat. C. Lynn Siegel
20:23
Aly-Khan A. Lalani

Choosing Wisely: 1L Combination Treatment for Advanced RCC

10:55
Yale Cancer Center

Systemic Therapies for Clear Cell RCC: Where Are We Now?

Feat. D. Braun